Update on gene therapy for myocardial ischaemia and left ventricular systolic dysfunction or heart failure

Archives of Cardiovascular Diseases

Volumn 103, Issue 8-9, 2010, Pages 469-476

  Roncalli, Jerome ^a,b,d   Tongers, Jörn ^a,c   Losordo, Douglas W ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d CHU RANGUEIL   (France)

Author keywords

Gene therapy; Heart failure; Left ventricular dysfunction

Indexed keywords

ADENOVIRUS VECTOR; CALCIUM; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PLACEBO; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SONIC HEDGEHOG PROTEIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN 189; VASCULOTROPIN 206; VASCULOTROPIN A;

ANGIOGENIC GENE THERAPY; CALCIUM TRANSPORT; CELL THERAPY; CLINICAL TRIAL; GENE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE VECTOR; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; MEDICAL RESEARCH; NONHUMAN; PATIENT SAFETY; REVIEW; TREATMENT RESPONSE;

ANGIOGENIC PROTEINS; ANIMALS; CALCIUM SIGNALING; GENE THERAPY; GENETIC VECTORS; HEART FAILURE; HUMANS; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; SYSTOLE; TRANSLATIONAL RESEARCH; VENTRICULAR DYSFUNCTION, LEFT;

EID: 78449274379     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2010.04.006     Document Type: Review

References (45)

1. D. Lloyd-Jones, R. Adams, and M. Carnethon Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 2009 480 486
2. T.T. Rissanen, and S. Yla-Herttuala Current status of cardiovascular gene therapy Mol Ther 15 2007 1233 1247
3. E. Leotta, G. Patejunas, and G. Murphy Gene therapy with adenovirus-mediated myocardial transfer of vascular endothelial growth factor 121 improves cardiac performance in a pacing model of congestive heart failure J Thorac Cardiovasc Surg 123 2002 1101 1113
4. D.W. Leung, G. Cachianes, and W.J. Kuang Vascular endothelial growth factor is a secreted angiogenic mitogen Science 246 1989 1306 1309
5. T.T. Rissanen, I. Vajanto, and M.O. Hiltunen Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration Am J Pathol 160 2002 1393 1403
6. S. Takeshita, L. Weir, and D. Chen Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia Biochem Biophys Res Commun 227 1996 628 635
7. S. Yla-Herttuala, T.T. Rissanen, and I. Vajanto Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine J Am Coll Cardiol 49 2007 1015 1026
8. H. Ueno, J.J. Li, and S. Masuda Adenovirus-mediated expression of the secreted form of basic fibroblast growth factor (FGF-2) induces cellular proliferation and angiogenesis in vivo Arterioscler Thromb Vasc Biol 17 1997 2453 2460
9. D.J. Ceradini, A.R. Kulkarni, and M.J. Callaghan Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 Nat Med 10 2004 858 864
10. P. Carmeliet, Y. Dor, and J.M. Herbert Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis Nature 394 1998 485 490
11. R. Pola, L.E. Ling, and M. Silver The morphogen sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors Nat Med 7 2001 706 711
12. K.F. Kusano, R. Pola, and T. Murayama Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signalling Nat Med 11 2005 1197 1204
13. M.A. Renault, J. Roncalli, and J. Tongers The hedgehog transcription factor Gli3 modulates angiogenesis Circ Res 105 2009 818 826
14. K. Tashiro, H. Tada, and R. Heilker Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins Science 261 1993 600 603
15. J.D. Abbott, Y. Huang, and D. Liu Stromal cell-derived factor-1 alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury Circulation 110 2004 3300 3305
16. B. Pieske, L.S. Maier, and D.M. Bers Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium Circ Res 85 1999 38 46
17. G. Hasenfuss, H. Reinecke, and R. Studer Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium Circ Res 75 1994 434 442
18. R.H. Schwinger, M. Bohm, and U. Schmidt Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts Circulation 92 1995 3220 3228
19. M. Hoshijima, Y. Ikeda, and Y. Iwanaga Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery Nat Med 8 2002 864 871
20. Y. Iwanaga, M. Hoshijima, and Y. Gu Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats J Clin Invest 113 2004 727 736
21. N.C. Lai, D.M. Roth, and M.H. Gao Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure Circulation 110 2004 330 336
22. M. Hedman, J. Hartikainen, and M. Syvanne Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT) Circulation 107 2003 2677 2683
23. J. Kastrup, E. Jorgensen, and A. Ruck Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris. A randomized double-blind placebo-controlled study: the Euroinject One trial J Am Coll Cardiol 45 2005 982 988
24. M.J. Wright, L.M. Wightman, and C. Lilley In vivo myocardial gene transfer: optimization, evaluation and direct comparison of gene transfer vectors Basic Res Cardiol 96 2001 227 236
25. J. Nalbantoglu, G. Pari, and G. Karpati Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells Hum Gene Ther 10 1999 1009 1019
26. K. Makinen, H. Manninen, and M. Hedman Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study Mol Ther 6 2002 127 133
27. J. Rutanen, T.T. Rissanen, and J.E. Markkanen Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart Circulation 109 2004 1029 1035
28. S. Yla-Herttuala, and K. Alitalo Gene transfer as a tool to induce therapeutic vascular growth Nat Med 9 2003 694 701
29. M. Gheorghiade, and R.O. Bonow Chronic heart failure in the United States: a manifestation of coronary artery disease Circulation 97 1998 282 289 (Pubitemid 28067315)
30. K.A. Vincent, C. Jiang, and I. Boltje Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease Gene Ther 14 2007 781 789
31. D.J. Stewart, J.D. Hilton, and J.M. Arnold Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF-121) versus maximum medical treatment Gene Ther 13 2006 1503 1511
32. D.W. Losordo, P.R. Vale, and J.F. Symes Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia Circulation 98 1998 2800 2804
33. P.R. Vale, D.W. Losordo, and C.E. Milliken Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia Circulation 102 2000 965 974
34. P.R. Vale, D.W. Losordo, and C.E. Milliken Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia Circulation 103 2001 2138 2143
35. C.L. Grines, M.W. Watkins, and G. Helmer Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris Circulation 105 2002 1291 1297
36. C.L. Grines, M.W. Watkins, and J.J. Mahmarian A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina J Am Coll Cardiol 42 2003 1339 1347
37. T.D. Henry, C.L. Grines, and M.W. Watkins Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT 3 and AGENT 4 trials J Am Coll Cardiol 50 2007 1038 1046
38. B.E. Jaski, M.L. Jessup, and D.M. Mancini Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial J Card Fail 15 2009 171 181
39. H.K. Hammond Adenylyl cyclase gene transfer in heart failure Ann N Y Acad Sci 1080 2006 426 436
40. C. Allera-Moreau, A. Delluc-Clavieres, and C. Castano Long-term expression of bicistronic vector driven by the FGF-1 IRES in mouse muscle BMC Biotechnol 7 2007 74
41. A. Rayssac, C. Neveu, and M. Pucelle IRES-based vector co-expressing FGF-2 and Cyr61 provides synergistic and safe therapeutics of lower limb ischemia Mol Ther 17 2009 2010 2019
42. S. Grundmann, J.J. Piek, and G. Pasterkamp Arteriogenesis: basic mechanisms and therapeutic stimulation Eur J Clin Invest 37 2007 755 766
43. A. Kawamoto, T. Murayama, and K. Kusano Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia Circulation 110 2004 1398 1405
44. R.S. Ripa, Y. Wang, and E. Jorgensen Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease Eur Heart J 27 2006 1785 1792
45. L.D. Shea, E. Smiley, and J. Bonadio DNA delivery from polymer matrices for tissue engineering Nat Biotechnol 17 1999 551 554